Effect of ARNI in Patients With Persistent AF and Enlarged Left Atrium After Catheter Ablation
Status:
Not yet recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this clinical randomized trial is to evaluate the efficacy and safety of
Sacubitril/Valsartan compared with ARB in improving cardiac remodeling in patients With
Enlarged Left Atrium Diameter and Persistent AF.
Phase:
N/A
Details
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Treatments:
LCZ 696 Sacubitril and valsartan sodium hydrate drug combination Valsartan